Titlebook: Infectious Complications in Bone Marrow Transplantation; Stephen C. Schimpff,Jean Klastersky Conference proceedings 1993 Springer-Verlag B

拍翅

Bone Marrow Transplantation for Cancer: An Overviewogeneic or syngeneic transplants during the years 1988–1990 (Bortin et al. 1992). Overall, it is estimated that over 32500 allogeneic or syngeneic transplants have been performed worldwide since the first successful transplant.

lambaste

Fever and Granulocytopenia: A Viewpoint from an Academic Setting suggest a source for the neutropenic fever, and the expected organisms and their resistance patterns within that particular hospital. Clearly, if prospective clinical trials of antibiotic regimens are available, patients should be entered into such trials (Table 1).

赤字

MEEK

抒情短詩(shī)

Introduction to Case Presentation to be consistent with the type of problems commonly encountered by clinicians caring for patients who have undergone a bone marrow transplant. The questions were designed to be straightforward yet raise issues for which the answer is frequently controversial. There was lively discussion regarding m

使厭惡

暗諷

Approach to the Patient with Prolonged Granulocytopeniaen fever occurs. However, the survival of the patient depends not only on the infectious agent(s) responsible for the initial fever and the antibiotics chosen for the primary empiric therapy, but also on the duration of the neutropenia, the secondary infections that arise, and the adjustments or mod

excursion

Simplification of Empiric Therapy for the Febrile, Neutropenic Oncology Patient the game of chess, once a few basic rules are learned, a handful of principles are comprehended and a set of opening moves that have passed extensive field testing are adopted, empiric therapy of febrile, neutropenic cancer patients can be surprisingly straightforward in many respects. Management s

Acetaminophen

缺乏

Empiric Antimicrobial Therapy in the Community Hospital Setting for the Cancer Patient with Fever an of bacteremia is approximately 20% (Consensus Panel, Immunocompromised Host Society 1990; Klastersky et al. 1988; Hughes et al. 1990; de Pauw et al. 1990; Pizzo 1989; Hathorn 1989; Lazarus et al. 1989). Untreated or inadequately treated, these infections are often rapidly fatal. The timely and effe